Trial
NCT02242409
Study of Gemcitabine and Abraxane for Pancreas Cancer
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Georgetown University
Collaborators
—
Condition
Pancreatic Cancer
Intervention
Gemcitabine and Abraxane
Why stopped
Testing of combination no longer relevant
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-02-14